Research never stops


Nov 08, 2017

Evotec AG announces first nine-month 2017 results and corporate update

Hamburg, Germany, 08 November 2017: Evotec AG today reported financial results and corporate updates for the first nine months of 2017.

- read more
Nov 21, 2017

Webinar "Immuno-Oncology: Therapeutic Strategies for Harnessing the Immune System Against Cancer"

Evotec is co-presenting a complimentary Webinar on Thursday 30 November 2017: for detailed information and the registration form, please click here.   

- read more
Nov 09, 2017

Evotec to attend upcoming investor conferences

Hamburg, Germany, 09 November 2017: Evotec AG announced today that its management will be attending the following conferences:

  • Jefferies 2017 London Healthcare Conference, London, UK
  • DZ BANK Equity Conference, Frankfurt, Germany
  • German Equity Forum, Frankfurt, Germany
  • dbAccess Pharmaceutical and Healthcare Corporate Day, London, UK
  • Annual Berenberg European Conference, Surrey, UK

- read more
Nov 06, 2017

Evotec joins forces with academic leaders to accelerate drug discovery in kidney diseases and build "NEPLEX"

Hamburg, Germany, 06 November 2017:
Evotec AG today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell ("iPSC") differentiation with leading academic institutions in the UK and Italy to accelerate the discovery of novel drugs to treat kidney diseases.

- read more
Oct 26, 2017

Evotec and Tesaro enter strategic partnership to discover novel immuno-oncology agents

Hamburg, Germany, 26 October 2017:
Evotec AG and TESARO, Inc. today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology target.

- read more
Oct 10, 2017

Evotec achieves first milestone in neurodegeneration alliance with Celgene

Hamburg, Germany, 10 October 2017: Evotec AG announced today that its strategic alliance with Celgene has reached a first milestone triggering revenues of $ 5.0 m to Evotec, which are recognised in the third quarter of 2017.

- read more
Sep 28, 2017

Evotec invests in Exscientia to advance AI-driven drug discovery

Hamburg, Germany, Dundee, UK, 28 September 2017: Evotec AG and Exscientia Ltd today announced that Evotec has made a EUR 15 m investment to take a minority stake in Exscientia.

- read more
Sep 14, 2017

Evotec and MaRS Innovation establish Academic Bridge "LAB150" in Toronto

Hamburg, Germany, 14 September 2017: Evotec AG and MaRS Innovation today announced the launch of "LAB150".

- read more
Sep 08, 2017

European Investment Bank supports Evotec´s Innovate strategy with € 75 m loan

Hamburg/Germany; Brussels/Belgium, 08 September 2017:
Evotec AG and the EIB announced today that the EIB has granted Evotec an unsecured loan facility of up to EUR 75 m to support Evotec's Innovate strategy.

Please find here the presentation

- read more
Sep 07, 2017

Evotec and ABIVAX enter into strategic collaboration to develop novel antiviral agents

Aug 16, 2017

Evotec completes acquisition of Aptuit

Aug 10, 2017

Evotec announces first half year 2017 results and corporate update

Aug 03, 2017

Evotec and Fraunhofer IME-SP sign strategic collaboration on iPSC technology

Jul 30, 2017

Evotec to acquire Aptuit, expanding leadership in external innovation

Jul 27, 2017

Evotec expands collaboration with STORM Therapeutics on its RNA epigenetic platform

Jul 24, 2017

Evotec and Bayer advance endometriosis programme into Phase I clinical development and extend alliance

Jul 06, 2017

Evotec received funding from IFB Hamburg to identify antibody-mediated t-cell immunotherapies

Jun 28, 2017

Evotec expands iPSC drug discovery leadership through strategic collaboration with Censo Biotechnologies

Jun 22, 2017

LAB282 accelerates with second round funding

Jun 20, 2017

Evotec announces strategic investment in Facio Therapies to support development of novel FSHD therapy

Jun 16, 2017

Evotec receives European Mediscience Award for 'Company of the Year'

Jun 14, 2017

Resolutions of the Annual General Meeting 2017 of Evotec AG

Jun 14, 2017

Evotec joins NURTuRE consortium to mine unique kidney disease patient biobank

May 22, 2017

Evotec receives pre-clinical milestone as part of its Endometriosis Alliance with Bayer

May 10, 2017

Evotec announces first quarter results 2017 and corporate update

Apr 05, 2017

Evotec achieves first milestone in Diabetes alliance with Sanofi

Mar 31, 2017

Evotec´s partner Forge Therapeutics receives prestigious Carb-X research award

Mar 28, 2017

Evotec fiscal year results 2016: Leading innovation efficiency & First-in-class drug discovery

Mar 03, 2017

Great story - Short film

Please click here and enjoy.

- read more
Feb 21, 2017

Evotec AG: 'LAB282' awarded first projects

Feb 09, 2017

Novo A/S becomes new long-term strategic shareholder in Evotec

Jan 26, 2017

Cyprotex, an Evotec company, expands into new UK facility at Alderley Park

Jan 19, 2017

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma (Japan)

Jan 17, 2017

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics

Jan 12, 2017

Haplogen´s novel antiviral target partnered with Evotec published in 'Nature'

Jan 09, 2017

Evotec and Eternygen to develop novel metabolic disease therapy